# Third author revision after independent adversarial review two

2026-11-02. Local working tree only. No Git, installs, network writes, agents,
publication or shipment. Save/cloud, loading/entry UI, character art,
service-queue routing, spatial and released evidence lanes were untouched.
The manager-owned CURRENT_THREAD_HANDOFF was read and was not overwritten.

## Result and review state

The two requested packets are regenerated:
[round three](question-round3-20261102.json) and
[batch one](question-batch1-20261102.json), with 43 main and 30 context items.
Their before fields show the exact v5 drafts assessed in
[independent review two](question-batch1-adversarial-review2-20261102.json);
previousAuthoringComparison retains the earlier comparison.

All seventeen independent PASS versions are exact, including their authored
questions, runtime nodes, shared presentations and finite profiles. They have
`pipelinePassed: true`, bound review/version metadata and no new clinical
approval. The 56 returned identities advance to v6 and remain
`needs_clinician_review`, with `pipelinePassed: false`.

- 21 application revisions: 15 main items and 6 contexts.
- 35 `basicRecallIntentional` items: 13 main items and 22 contexts, each with a
  one-line reason. These are explicitly basic, not counted as failed attempts
  at resident difficulty. The designation itself does not confer independent
  PASS; its scope is visible for manager/reviewer assessment.
- All 999 indexed second-review notes have responses: 34 cues, 807 fairness
  notes and 158 suggestions, including all 586 earlier-note assessments.
- Melissa's eleven exact historical clinical approvals remain unchanged:
  A04/A08/A17/A22/A23/A27/A28/A38 on 2026-10-29 and A11-r2/A30-r2/A40-r2 on
  2026-11-02. No approval transfers to a new version, claim, concept or profile.

The [response/intent ledger](question-adversarial-round3-response-20261102.md)
lists each item, its exact version, changed decision and basic justification.
The author self-check is not independent acceptance or observed difficulty.

## Substantive changes

Application items now ask for a consequential interpretation and plan:

- A06 compares balanced breast/endocrine sequences; every option addresses
  both. Its context requires reading an outside noncontrast implant-MRI
  protocol rather than treating an intact implant report as a discharge workup.
- A25 deletes the service-availability rationale. Its context interprets
  ventilation changes despite movement/maintained oxygen saturation and
  compares equal-component sedation/ART plans, without doses or washouts.
- B02 specifies the primary ten-swallow protocol and failed rather than
  premature contractions. B03 adds documented oxycodone exposure before
  irreversible treatment planning. B04 combines measured contraction failure
  with weight/scope observations that challenge premature primary diagnosis.
- B11/B17 coordinate indicated regional staging with proposed flap/graft
  reconstruction. B12/B18 honestly retain the basic staging-indication role.
- B13-B16 contexts interpret actual previous imaging coverage/acquisitions.
  B15 supplies grade, transected/unmeasurable invasive depth and operative
  suitability, without inventing LVI/poor grade to force surgery; its key stays
  at broad regional-treatment scope rather than a precise transverse operation.
- B19/B20 restore the original method/planning construct: two viable intramass
  targets compete through different muscle-compartment paths. Core/open method
  and path components occur equally. The safe letter differs across siblings.
- B24 weighs a clonal B-cell result against the actual gland-preserving
  morphology before selecting repeat integrated assessment, predictive fusion
  testing or repeat clonality.
- B26/B27/B39 name adverse endpoints and benefit direction and state the
  hypothetical whole-interval criterion. Values are unchanged; interval-based
  exclusion is not described as impossibility.
- B36 supplies task-level time and actual record agreement, names concrete
  next modifications and treats the key as a testable hypothesis, not proof.

Basic items retain necessary findings. Fixes include complete skin-lesion
extent and concrete closure feasibility, removal of B12's darkest-versus-
thickest anti-distractor sentence, removal of the MALT large-cell negative,
consolidated morphology, genuine same-region MRI alternatives, removal of
unchanged repeat-aspiration/ultrasound fillers, explicit constructed discharge
criteria, mutually exclusive IV/oral CT protocols, and neutral coherent
duodenal clip-failure observations. No false lesion-specific superiority is
invented between several accepted hemostatic methods.

## Evidence, lint and preservation

[Source ledger](sources-question-adversarial-r3-20261102.md): eighteen scoped
supporting records and twenty-two atomic claims, all pending clinical review. Authority,
rights, access route, date, limitations and claim/item mappings are separate.
Current primary guidance is preferred; older technical support and single-
source limitations are explicit. The opioid and reconstruction claims have low
certainty. Four anatomical membership claims map the new thigh/arm route
observations separately from the two management/planning claims. OpenStax was
excluded when its AI restriction was found; temporary pandemic reuse permission
was not assumed adequate for another candidate. No article/source prose or
restricted corpus was stored.

Linter v5 is unchanged and used on both sides. Whole-bank findings change
1,724 / 886 flagged variants to 1,741 / 890; the selected 73 items change
45 findings / 34 flagged to 62 / 38. There are 1,418 distinct variants,
1,110 cases, 1,423 node occurrences, 370 concepts and 6,039 profile contexts.
The increase is visible, particularly in shared components of balanced plan
sets and explicit contrast protocols. Every retained warning has its exact
phrases/fields and a review reason. No rules are suppressed to reduce counts.
Automated lint cannot certify clinical ranking, difficulty or the basic label.

All 370 concept definitions/IDs remain unchanged. The added decisions apply
the existing objective; Melissa must confirm construct equivalence, especially
the motility/secondary-cause and sedation/monitoring applications. A material
change of clinical meaning requires a new concept version before approval.
The B19/B20 method component is restored rather than silently retaining a
target-only substitute for the original objective.

All 1,613 entry timing rows remain exact; 56 new rows make 1,669. Nine new exact
registry records clone prior dispositions. No new gate identity/type, route,
service execution, queue behavior, wait value, save schema or learning-history
ID is introduced. Runtime now has 1,473 timed choices and 140 terminal timed
keys: the four added timed alternatives are two A06 pituitary-MRI plans and
one extra biopsy plan in each sarcoma case.

Three domain files changed: `src/test-choice-orders.ts`,
`tests/test-choice-order-inventory.test.ts` and
`tests/gs028-20261007-level3-batch.test.ts`, under packages/game-domain.
The Level 3 count changes 318 to 319 solely because A25-context now has four
balanced plans rather than three. All eighty nodes, exact choice coverage,
FSRS, service/no-extra-order and frozen/save assertions remain.
No player source/test file changed this round; four presentation suites were
tested. No deadline or assertion was weakened.

## Validation

The machine receipt is `tools/question-quality/adversarial-r3-validation-20261102.json`;
logs use the same `adversarial-r3-` prefix under tools/question-quality.

| Check | Exact result |
| --- | --- |
| Clinical-content, threads/maxWorkers=2 | 93 files; 731 passed, 0 failed; 30.50s |
| Cue-linter tests | 21 passed, 0 failed; 46.6407ms |
| Whole-bank advisory lint | Completed; 1,741 findings / 890 flagged / 1,418 variants |
| Four touched player presentation suites, preload + threads/maxWorkers=2 | 4 files; 43 passed, 0 failed; 6.06s |
| Full game-domain, threads/maxWorkers=2 | 166 files: 164 passed / 2 failed; 4,367 passed / 5 failed / 1 skipped (4,373 tests); 846.86s |
| Typecheck | All seven workspaces passed |
| Report/source/compatibility QA | Passed: 73 items, 999 indexed responses, 586 earlier-note assessments, 32,599 reconstructed spans (182 post-answer), six numerical checks, 11 exact approvals and nine protected files |

Exactly one domain failure is solely the expected input-binding mismatch:
`tests/level-five-integration.test.ts > M9 connected Level 5 reducer journey > binds the actual run to its current game, balance, clinical and driver inputs and reconciles cash`.
The first mismatching file is answer-choice-timing.ts: recorded
`ad821c697ca2c8f6553ea03affd0cb868db65b56418c29e1c000307e771358eb`, current
`a296bdc8d62bc5ae11fe3943dbc75e9268a8cd5e50d59b83746a2750eaace7ff`.
The other four failures are timeouts, not binding failures:

- `tests/level-five-integration.test.ts > M9 connected Level 5 reducer journey > matches continued play after save/reload at integration-running` (30,000ms).
- `tests/level-five-integration.test.ts > M9 connected Level 5 reducer journey > continues normal operations, completes a genuinely lower retry and retains the higher best and first finish` (300,000ms).
- `tests/level-five-latent-bugs.test.ts > Level 5 garden and diagnostic movement ownership > finishes the garden return before starting offsite movement after live` (5,000ms).
- The same garden-return test after `legacy reload` (5,000ms).

All four were also observed in the preceding v5 full run. Manager previously
confirmed three pre-pilot timeouts and declined spatial.ts optimization; no
new claim is made that every additional checkpoint timeout was proven
pre-existing. Both Level 5 test files, spatial.ts and every deadline remain
byte-identical to entry. A rebind must not be represented as fixing timeouts.
The full domain suite is not green. No broad follow-up excluding failures is
represented as a replacement for this full result.

Question stems/options were frozen before the full domain run. Two evidence-
certainty fields were later lowered, and four anatomy claim mappings/three
source records added. Those metadata-only edits do not change domain behavior;
the final clinical-content, typechecks, whole-bank lint and report QA above
include them. No player file changed this round; the four tested suites are
variety3ChartsViewModels, briefEarlyLevelsPresentation, pediatricChartsViewModels
and earlyLevelsPresentation under apps/player/src/session. No full-player
result is claimed for this round.

## Exact Level 5 inputs and files

Read-only receipt:
`tools/question-quality/adversarial-r3-bound-inputs-20261102.json`.
This round edits six existing bound files:

- packages/clinical-content/src/answer-choice-timing.ts
- packages/clinical-content/src/index.ts
- packages/clinical-content/src/synthetic-content.ts
- packages/clinical-content/src/question-quality-pilot-20261028.ts
- packages/clinical-content/src/question-quality-adversarial-20261102.ts
- packages/game-domain/src/test-choice-orders.ts

It adds three bound files:

- packages/clinical-content/src/question-quality-adversarial-r3-20261102.ts
- packages/clinical-content/src/question-quality-adversarial-r3-20261102-data.ts
- packages/clinical-content/src/question-quality-adversarial-r3-evidence-20261102.ts

The current collector has 397 inputs versus 378 in the retained evidence
manifest. Its nine recorded-path differences and nineteen additions include
previous milestones and unowned shared-tree files; those are separate from
this round's six edits/three additions. Existing evidence, checkpoints, driver
artifacts and spatial files remain exact. Manager must run the actual release-
lane rebind after acceptance; copying hashes is not a rebind.

The exact owned path/hash manifest is
`tools/question-quality/adversarial-r3-owned-files-20261102.json`.
Tests/tools/docs are excluded from the runtime binding collector under its
existing rules. Earlier authoring source and timing/binding records remain.

## Handoff / remaining review

Return both current packets for independent re-review, including the scope of
the 35 basic labels. Verify closest distractors and unique ranking in the 21
applications, changed preceding feedback, imaging protocol adequacy, medication
care, melanoma reconstruction, colorectal margin scope, muscle anatomy and
gastric pathology. These reviewer predictions are not player measurements.

Manager owns review-page publication, acceptance/browser checks, clinical
version review, any rebind, integration, release and backup coordination.
Nothing shipped or was backed up by this worker; the result remains local.

## Exact owned path list

Thirty-eight source, test, tooling, fixture and documentation paths; exact hashes
are in the owned-file receipt. No player file was edited this round. Generated
JSON reports and validation logs are listed separately below.

```text
docs/clinical/question-authoring-standard.md
docs/execplans/question-bank-rewrite-20261102.md
docs/execplans/question-batch1-adversarial-round3-20261102.md
docs/research/question-round3-20261102.json
docs/research/question-batch1-20261102.json
docs/research/question-inventory-20261028.md
docs/research/sources-question-adversarial-r3-20261102.md
docs/research/question-adversarial-round3-response-20261102.md
docs/research/question-batch1-adversarial-round3-handoff-20261102.md
docs/research/question-batch1-adversarial-handoff-20261102.md
packages/clinical-content/src/question-quality-pilot-20261028.ts
packages/clinical-content/src/question-quality-adversarial-20261102.ts
packages/clinical-content/src/index.ts
packages/clinical-content/src/synthetic-content.ts
packages/clinical-content/src/answer-choice-timing.ts
packages/clinical-content/src/answer-choice-timing.test.ts
packages/clinical-content/src/question-quality-adversarial.test.ts
packages/clinical-content/src/question-quality-adversarial-r3-20261102.ts
packages/clinical-content/src/question-quality-adversarial-r3-20261102-data.ts
packages/clinical-content/src/question-quality-adversarial-r3-evidence-20261102.ts
packages/clinical-content/src/question-quality-adversarial-r3.test.ts
packages/game-domain/src/test-choice-orders.ts
packages/game-domain/tests/test-choice-order-inventory.test.ts
packages/game-domain/tests/gs028-20261007-level3-batch.test.ts
tools/question-quality/report.mjs
tools/question-quality/review-round3-batch1-20261102.mjs
tools/question-quality/verify-review-20261102.mjs
tools/question-quality/README.md
tools/question-quality/adversarial-r3-capture-20261102.mjs
tools/question-quality/adversarial-r3-specs-20261102.mjs
tools/question-quality/adversarial-r3-evidence-20261102.mjs
tools/question-quality/author-adversarial-r3-20261102.mjs
tools/question-quality/build-adversarial-r3-choice-records-20261102.mjs
tools/question-quality/review-adversarial-r3-20261102.mjs
tools/question-quality/write-adversarial-r3-docs-20261102.mjs
tools/question-quality/verify-adversarial-r3-20261102.mjs
tools/question-quality/adversarial-r3-bound-inputs-20261102.mjs
tools/question-quality/fixtures/adversarial-r3-before-20261102.json
```

Generated artifacts under tools/question-quality (all dated 20261102):

- adversarial-r3-cue-before, adversarial-r3-cue-after and adversarial-r3-cue-comparison JSON.
- adversarial-r3-exact-records, adversarial-r3-report-qa, adversarial-r3-whole-bank, adversarial-r3-bound-inputs, adversarial-r3-owned-files and adversarial-r3-validation JSON.
- Final clinical, lint-tests, whole-bank, player, domain-full, typecheck-final, report-qa and docs logs. Initial failed/focused logs remain historical; they are not final results.
